FR2331553B1 - - Google Patents
Info
- Publication number
- FR2331553B1 FR2331553B1 FR7634097A FR7634097A FR2331553B1 FR 2331553 B1 FR2331553 B1 FR 2331553B1 FR 7634097 A FR7634097 A FR 7634097A FR 7634097 A FR7634097 A FR 7634097A FR 2331553 B1 FR2331553 B1 FR 2331553B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/15—Oxytocin or vasopressin; related peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/631,408 US4033940A (en) | 1975-11-12 | 1975-11-12 | Cyclization of peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2331553A1 FR2331553A1 (fr) | 1977-06-10 |
FR2331553B1 true FR2331553B1 (fr) | 1980-11-28 |
Family
ID=24531072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7634097A Granted FR2331553A1 (fr) | 1975-11-12 | 1976-11-12 | Procede perfectionne de cyclisation des peptides et peptides utilisables comme produits intermediaires dans ce procede |
Country Status (5)
Country | Link |
---|---|
US (1) | US4033940A (fr) |
JP (1) | JPS5259179A (fr) |
DE (1) | DE2647843A1 (fr) |
FR (1) | FR2331553A1 (fr) |
GB (1) | GB1568981A (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4216141A (en) * | 1978-07-19 | 1980-08-05 | The Salk Institute For Biological Studies | Method for cyclization of peptides |
US4212795A (en) * | 1978-11-13 | 1980-07-15 | Armour Pharmaceutical Company | Cyclization of peptides |
SE447263B (sv) * | 1979-04-20 | 1986-11-03 | Bonnierfoeretagen Ab | Syntetisk, antigeniskt aktiv polypeptid och antigeniskt medel innehallande nemnda polypeptid |
JPS58501121A (ja) * | 1981-07-15 | 1983-07-14 | セルテク リミテツド | ヒト カルシトニン前駆体ポリ蛋白質構造遺伝子 |
US4469632A (en) * | 1982-09-24 | 1984-09-04 | Armour Pharmaceutical Company | D-Arginine24 calcitonin |
US4444681A (en) * | 1982-09-24 | 1984-04-24 | Armour Pharmaceutical Company | L-Tyrosine21 calcitonin |
US4451395A (en) * | 1982-11-08 | 1984-05-29 | Armour Pharmaceutical Company | Des-serine2 -des-tyrosine22 calcitonin |
US4663309A (en) * | 1983-06-29 | 1987-05-05 | University Patents, Inc. | Novel peptide hormones with calcitonin-like activity |
US4528132A (en) * | 1984-01-13 | 1985-07-09 | Armour Pharmaceutical Company | [16-Alanine]calcitonin |
US4623716A (en) | 1984-11-01 | 1986-11-18 | Usv Pharmaceutical Corp. | Process for the preparation and purification of peptides |
JPS61112099A (ja) * | 1984-11-06 | 1986-05-30 | Mitsubishi Petrochem Co Ltd | 新規ポリペプチド及びその製造法 |
US4604238A (en) * | 1984-12-10 | 1986-08-05 | Armour Pharmaceutical Company | Analogs of calcitonin |
US4820804A (en) * | 1987-04-21 | 1989-04-11 | Rorer Pharmaceutical Corporation | Analogs of [1,7-di-alanine, des-19-leucine]calcitonin |
US4824936A (en) * | 1987-05-06 | 1989-04-25 | Rorer Pharmaceutical Corporation | (19-Alanine) calcitonin |
NZ268442A (en) * | 1993-06-29 | 1996-09-25 | Ferring Bv | Aqueous composition of desmopressin for nasal spray administration |
DE69424940T2 (de) * | 1993-06-29 | 2000-12-28 | Ferring Bv | Synthese zyklischer peptide |
US5674850A (en) * | 1993-12-23 | 1997-10-07 | Ferring Ab | High purity desmopressin produced in large single batches |
US5500413A (en) * | 1993-06-29 | 1996-03-19 | Ferring Ab | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
US5482931A (en) * | 1993-06-29 | 1996-01-09 | Ferring Ab | Stabilized pharmaceutical peptide compositions |
SE9400918L (sv) * | 1994-03-18 | 1995-09-19 | Anne Fjellstad Paulsen | Stabiliserad komposition för oral administrering av peptider |
US5763398A (en) * | 1996-06-20 | 1998-06-09 | Ferring B.V. | Nasal administration of desmopressin |
US5922680A (en) * | 1996-10-23 | 1999-07-13 | Ferring, B.V. | Stabilized composition for oral administration of peptides |
CA2484594C (fr) * | 2002-05-03 | 2012-06-26 | Avecia Limited | Procede de synthese de peptides |
WO2010027818A2 (fr) | 2008-08-25 | 2010-03-11 | Dana-Farber Cancer Institute, Inc. | Epitope conservé d'hémagglutinine, anticorps contre l'épitope et procédés d'utilisation |
TW201029663A (en) * | 2008-11-12 | 2010-08-16 | Theraclone Sciences Inc | Human M2e peptide immunogens |
WO2010135277A2 (fr) | 2009-05-18 | 2010-11-25 | Brown University | Analogues de glur6 cyclique, procédés de traitement et d'utilisation |
US10106579B2 (en) | 2014-06-12 | 2018-10-23 | Ra Pharmaceuticals, Inc. | Modulation of complement activity |
US9937222B2 (en) | 2015-01-28 | 2018-04-10 | Ra Pharmaceuticals, Inc. | Modulators of complement activity |
US20180118799A1 (en) | 2015-04-13 | 2018-05-03 | National Institute Of Advanced Industrial Science And Technology | Cyclized cytokine and method for producing same |
ES2914590T3 (es) | 2015-11-09 | 2022-06-14 | Tufts College | Compuestos y métodos de tratamiento del dolor |
TWI745320B (zh) | 2015-12-16 | 2021-11-11 | 美商Ra製藥公司 | 補體活性之調節劑 |
CN110087668A (zh) | 2016-12-07 | 2019-08-02 | Ra制药公司 | 补体活性的调节剂 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3929758A (en) * | 1974-09-12 | 1975-12-30 | Armour Pharma | Cyclization of cysteine-containing peptides |
-
1975
- 1975-11-12 US US05/631,408 patent/US4033940A/en not_active Expired - Lifetime
-
1976
- 1976-10-14 JP JP51123378A patent/JPS5259179A/ja active Granted
- 1976-10-22 DE DE19762647843 patent/DE2647843A1/de not_active Ceased
- 1976-10-26 GB GB44382/76A patent/GB1568981A/en not_active Expired
- 1976-11-12 FR FR7634097A patent/FR2331553A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
DE2647843A1 (de) | 1977-05-26 |
JPS5259179A (en) | 1977-05-16 |
FR2331553A1 (fr) | 1977-06-10 |
GB1568981A (en) | 1980-06-11 |
JPS6140680B2 (fr) | 1986-09-10 |
US4033940A (en) | 1977-07-05 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |